Advertisement

Topics

Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform

14:00 EDT 22 Sep 2016 | Biotech 365

Breast Cancer Index & CancerTYPE ID Tests Provide Patient-Specific Information to Aid in Treatment Decisions with the Goal of Improving Outcomes SAN DIEGO & PALO ALTO, Calif.–(BUSINESS WIRE)–Biotheranostics, Inc., a pioneer in molecular diagnostics for cancer, and Syapse, the leader … Continue reading

Cet article Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform est apparu en premier sur Biotech 365.

Original Article: Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform

NEXT ARTICLE

More From BioPortfolio on "Biotheranostics & Syapse Collaborate to Integrate Genomics-Based Molecular Diagnostics for Cancer into the Syapse Precision Medicine Platform"

Quick Search
Advertisement
 

Relevant Topic

Diagnostics
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...